Lamya Hamad

2.8k total citations
11 papers, 92 citations indexed

About

Lamya Hamad is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Lamya Hamad has authored 11 papers receiving a total of 92 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 2 papers in Molecular Biology and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Lamya Hamad's work include Cancer Immunotherapy and Biomarkers (6 papers), Advanced Breast Cancer Therapies (2 papers) and CAR-T cell therapy research (2 papers). Lamya Hamad is often cited by papers focused on Cancer Immunotherapy and Biomarkers (6 papers), Advanced Breast Cancer Therapies (2 papers) and CAR-T cell therapy research (2 papers). Lamya Hamad collaborates with scholars based in United States. Lamya Hamad's co-authors include Marc S. Ernstoff, Chong Wang, Yara Abdou, Shipra Gandhi, Elizabeth Repasky, Mark J. Bucsek, Ankita Kapoor, Manu Pandey, Kilian Salerno and Mateusz Opyrchal and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Medicine.

In The Last Decade

Lamya Hamad

9 papers receiving 89 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lamya Hamad United States	6	50	13	13	12	11	11	92
Henk van Halteren Netherlands	5	40 0.8×	9 0.7×	14 1.1×	9 0.8×	21 1.9×	8	98
Shin‐ichi Tsujimoto Japan	8	26 0.5×	48 3.7×	22 1.7×	9 0.8×	15 1.4×	21	139
Elnaz Naderi Netherlands	7	20 0.4×	21 1.6×	12 0.9×	24 2.0×	28 2.5×	14	97
Laimin Luo China	7	18 0.4×	36 2.8×	17 1.3×	16 1.3×	13 1.2×	17	124
Susan A. Tyler Canada	5	24 0.5×	13 1.0×	4 0.3×	12 1.0×	7 0.6×	7	105
Adrienne E. Borrie Canada	6	40 0.8×	15 1.2×	14 1.1×	5 0.4×	3 0.3×	6	77
Yehia I. Abugabal United States	3	24 0.5×	15 1.2×	13 1.0×	12 1.0×	26 2.4×	12	80
Frank Cornélis Belgium	4	34 0.7×	28 2.2×	27 2.1×	6 0.5×	15 1.4×	8	169
Claudia Ruffert Germany	6	126 2.5×	14 1.1×	25 1.9×	4 0.3×	30 2.7×	9	219

Countries citing papers authored by Lamya Hamad

Since Specialization

Citations

This map shows the geographic impact of Lamya Hamad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lamya Hamad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lamya Hamad more than expected).

Fields of papers citing papers by Lamya Hamad

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lamya Hamad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lamya Hamad. The network helps show where Lamya Hamad may publish in the future.

Co-authorship network of co-authors of Lamya Hamad

This figure shows the co-authorship network connecting the top 25 collaborators of Lamya Hamad. A scholar is included among the top collaborators of Lamya Hamad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lamya Hamad. Lamya Hamad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Puzanov, Igor, et al.. (2024). Evaluation of safety outcomes between nivolumab regimens with differing dosing patterns. Journal of Oncology Pharmacy Practice. 31(6). 895–901.

Hamad, Lamya, et al.. (2024). The relationship between both biomarkers miR-21 and CA15-3 values and the clinic-pathological features of breast cancer Iraqi patients. Research Journal of Biotechnology. 19(11). 222–228.

Hamad, Lamya, et al.. (2023). Making sense of the dollars: Evaluation of financial toxicity in patients of breast medicine receiving oral chemotherapy at Roswell Park.. Journal of Clinical Oncology. 41(16_suppl). e18519–e18519. 1 indexed citations

Sharma, Rajeev, et al.. (2023). Incidence of diabetes mellitus in patients treated with immune checkpoint inhibitors (ICI) therapy – A comprehensive cancer center experience. Diabetes Research and Clinical Practice. 202. 110776–110776. 8 indexed citations

Zhang, Zhen, et al.. (2020). 856 Preliminary review of Diabetes Mellitus incidence in patients treated with immune checkpoint inhibitors (ICI) therapy – Roswell Park Comprehensive Cancer Center (RPCCC) experience. SHILAP Revista de lepidopterología. A510.1–A510. 1 indexed citations

Gandhi, Shipra, Manu Pandey, Chong Wang, et al.. (2020). Impact of Concomitant Medication Use and Immune-Related Adverse Events on Response to Immune Checkpoint Inhibitors. Immunotherapy. 12(2). 141–149. 25 indexed citations

Hamad, Lamya, et al.. (2019). Oral Anticancer Therapy: Management of Drug Interactions. Journal of Oncology Practice. 15(2). 81–90. 31 indexed citations

Abdou, Yara, Ankita Kapoor, Lamya Hamad, & Marc S. Ernstoff. (2019). Combination of pembrolizumab and imatinib in a patient with double KIT mutant melanoma. Medicine. 98(44). e17769–e17769. 10 indexed citations

Gandhi, Shipra, Manu Pandey, Katy Wang, et al.. (2017). Clinical and biochemical parameters as predictors of response to checkpoint inhibitors (CPI): A single institution experience.. Journal of Clinical Oncology. 35(15_suppl). e14590–e14590. 2 indexed citations

10.

Hamad, Lamya, et al.. (2016). A Case of Metaplastic Breast Cancer with Prolonged Response to Single Agent Liposomal Doxorubicin. Cureus. 8(1). e454–e454. 9 indexed citations

11.

Hamad, Lamya, et al.. (2016). Alteplase Use in Surface-Modified Peripherally Inserted Central Catheters in a National Cancer Institute-Designated Comprehensive Cancer Center: A Pharmacoeconomic Analysis. Journal of the Association for Vascular Access. 21(1). 39–43. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact